Skip to content

The effectiveness of calcium versus ibuprofen in reducing pain among a group of orthodontic patients

The effectiveness of calcium versus ibuprofen in reducing pain among a group of orthodontic patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625000402448
Enrollment
78
Registered
2025-05-02
Start date
2024-12-14
Completion date
2025-07-03
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Objectives of the study 1.3.1 General objective: • To evaluate the effectiveness of calcium supplementation compared to ibuprofen in reducing pain following orthodontic elastic separators placement using a randomized clinical trial design. 1.3.2 Specific objectives: • To assess the onset of pain relief and duration of action for both calcium and ibuprofen in a group of orthodontic patients. • To investigate any potential side effects associated with each treatment option. • To investigate the association of pain intensity with age and gender. Study hypothesis 1.4.1 Null hypothesis (H0): • There is no statistically significant difference in pain reduction between orthodontic patients who receive calcium supplementation and those who receive ibuprofen following orthodontic elastic separators placement. • There is no statistically significant association between pain intensity with age and gender of orthodontic patients who receive calcium supplementation and those who receive ibuprofen following orthodontic elastic separators placement. • There is no statistically significant difference in side effects prevalence between orthodontic patients who receive calcium supplementation and those who receive ibuprofen following orthodontic elastic separators placement. 1.4.2 Alternative hypothesis (H1): • There is statistically significant difference in pain reduction between orthodontic patients who receive calcium supplementation and those who receive ibuprofen following orthodontic elastic separators placement. • There is statistically significant association between pain intensity with age and gender of orthodontic patients who receive calcium supplementation and those who receive ibuprofen following orthodontic elastic separators placement. • There is statistically significant difference in side effects prevalence between orthodontic patients who receive calcium supplementation and those who receive ibuprofen following orthodontic elastic separators placement.

Interventions

Application of pain trigger (Orthodontic Separator Placement) to the the participants by the main researcher by using separator placement plier The duration of the procedure is approximately two minutes The orthodontic elastic separator will remain in place one week after and experience of pain relief Ibuprofen 500 mg oral tablet is taken two hours after procedure one tablet daily for one week strategy used to monitor adherence to the intervention by tablet count

Sponsors

Sadiq Abdullah Dhafir Hamud Atif, orthodontic resident university of Science and Technology
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
All
Age
18 Years to 28 Years
Healthy volunteers
No

Inclusion criteria

1. Patients who need orthodontic treatment with fixed orthodontic appliances (braces). 2. Early adult patients aged 18-28 years old. 3. Patients who are scheduled for a specific orthodontic procedure known to cause pain (separator placement). 4. Orthodontic patients who are generally healthy with no major medical conditions that could influence pain perception or medication use such as chronic pain, ventricular filtration, renal calculi, kidney diseases, uncontrolled diabetes mellitus, bleeding disorders, hyperthyroidism and calcium supplement intake. 5. Absence of allergies to calcium or ibuprofen. 6. Willingness, ability, and understanding to adhere to the study protocol, including taking medications as instructed and attending follow-up assessments. 7. Initial pain intensity between 40 and 100 mm (VAS). 8. Initial Hospital Anxiety Depression Scale (HADS) scoring between 0 and 10.

Exclusion criteria

1. Pregnancy or breastfeeding. 2. Taking medications that could interact with calcium or ibuprofen, such as thyroid medications, bisphosphonates, diuretics, corticosteroids, other NSAID, and blood thinners. 3. Previous participation in a similar study within a specific timeframe.

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 4, 2026